Valneva SE (VALN) Beginning Cash Balance (2021 - 2023)
Valneva SE (VALN) posted Beginning Cash Balance of $307.5 million for Q1 2023, down 20.95% sequentially from $389.0 million in Q1 2022, and down 20.95% YoY from $389.0 million in Q1 2022.
Valneva SE (VALN) Beginning Cash Balance (2021 - 2023) Analysis & Trends
Valneva SE has reported Beginning Cash Balance for 3 years, with the latest figure at $307.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 311.92 Mn |
| Sep 30, 2023 | 311.92 Mn |
| Jun 30, 2023 | 312.01 Mn |
| Jun 30, 2023 | 312.01 Mn |
| Mar 31, 2023 | 307.55 Mn |
| Mar 31, 2023 | 307.55 Mn |
| Mar 31, 2022 | 389.05 Mn |
| Mar 31, 2022 | 389.05 Mn |
| Mar 31, 2021 | 246.55 Mn |
| Mar 31, 2021 | 246.55 Mn |